Han Jung

Corporate Officer/Principal at Korean Institute of Certified Public Accountants

Health Technology

Han Jung active positions

Companies	Position	Start	End
Korean Institute of Certified Public Accountants	Corporate Officer/Principal	-	-

Companies	Position	Start	End
Glycostem Therapeutics BV Glycostem Therapeutics BV BiotechnologyHealth Technology Glycostem Therapeutics BV operates as a life science company which develops cellular immunotherapy and production technology platforms. It develops cellular immunotherapeutic for the treatment of leukemia, lymphomas, and other forms of cancer. The firm provides Prototype NK-cell and NK-cell progenitor cell products for clinical evaluations and intervention studies; and GBGM, a cell survival and minimal cellular delineation in expansion and differentiation experiments. The company was founded by Dirk Groenewegen and Jan van der Hoeven in 2007 and is headquartered in Oss, the Netherlands.	Director/Board Member	-	-

International

Netherlands	2
South Korea	2

Operational

Director/Board Member	1
Corporate Officer/Principal	1

Sectoral

Health Technology

Positions held

Active

Inactive

Listed companies

Private companies

Private companies	2
Glycostem Therapeutics BV Glycostem Therapeutics BV BiotechnologyHealth Technology Glycostem Therapeutics BV operates as a life science company which develops cellular immunotherapy and production technology platforms. It develops cellular immunotherapeutic for the treatment of leukemia, lymphomas, and other forms of cancer. The firm provides Prototype NK-cell and NK-cell progenitor cell products for clinical evaluations and intervention studies; and GBGM, a cell survival and minimal cellular delineation in expansion and differentiation experiments. The company was founded by Dirk Groenewegen and Jan van der Hoeven in 2007 and is headquartered in Oss, the Netherlands.	Health Technology
Korean Institute of Certified Public Accountants

Private companies

Health Technology

Korean Institute of Certified Public Accountants